Quotient Limited Release: Company To Report Third Quarter Fiscal 2017 Financial Results And Host Conference Call Post author:Sam Post published:January 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>President Trump</b> Tosses Tweet-Bomb at Drug Industry, Stocks Drop March 6, 2017 Ascendis Announces Pricing Of Public Offering Of ADSs September 26, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017